Randomized, placebo controlled, double blinded pilot superiority phase 2 trial to evaluate the effect of curcumin in moderate to severe asthmatics.
BMC Pulm Med
; 21(1): 268, 2021 Aug 17.
Article
in En
| MEDLINE
| ID: mdl-34404358
Key words
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
/
2_ODS3
/
4_TD
Database:
MEDLINE
Main subject:
Asthma
/
Immunoglobulin E
/
Curcumin
/
Eosinophils
/
COVID-19
/
COVID-19 Drug Treatment
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Guideline
/
Prognostic_studies
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
BMC Pulm Med
Year:
2021
Document type:
Article